Infection Prevention and Control Implications of Special Pathogens in Children

• 2024

  Log in to bookmark this resource.

  Log in
• Larry Kociolek; Andi Shane; Kari Simonsen; Danielle Zerr
PMID: 38754934DOI: https://doi.org/10.1016/j.pcl.2024.01.014

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

Special pathogens, highly transmissible and causing severe disease, require Children's hospital healthcare personnel (HCP) to identify, isolate, and inform to prevent transmission. This article discusses how preparedness involves education, policies, drills, training, and supplies. This readiness is crucial in a global age where pathogens easily cross borders, emphasizing the importance of keeping communities, HCP, patients, and families safe.
This article is part of a series in Pediatrics Clinics of North America 2024 June; 71(3).

---

Tags

Focus Area: Infectious Disease

Audience: Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Keywords: Communicable Disease Control; Communicable Diseases; Cross Infection; Marburg Virus Disease; Personnel, Hospital; Infection Control

Institutions: Northwestern University; Emory University; University of Nebraska Medical Center; Seattle Children's Hospital; University of Washington

---

More like this

Pediatric Mental Health Boarding in US Emergency Departments, 2018-2022 2025 · Ann and Robert H. Lurie Children’s Hospital, Northwestern University, University of California San Francisco, Children's National Hospital, George Washington University, Seattle Children's Hospital, UH Rainbow Babies & Children's Hospital, Case Western Reserve University School of Medicine, Pediatric Pandemic Network (PPN), Harbor-UCLA Medical Center, University of California, Los Angeles International Consensus Criteria for Pediatric Sepsis and Septic Shock 2024 · University of Zurich, The University of Queensland, University of Washington, Seattle Children's Hospital, Ann and Robert H. Lurie Children’s Hospital, Northwestern University Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024 2024 · Centers for Disease Control and Prevention (CDC), U.S. Public Health Service, University of Rochester, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Vanderbilt University, Texas Children's Hospital, Baylor College of Medicine, University of Washington, University of Pittsburgh, Children's Mercy Kansas City

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---